SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
19-Dec-22 7:09 AM View: | Nrx Pharmaceuticals, Inc. (NRXP) | 16-Dec-22 | Private Purchase | 30,000 | $1.10 | $33,000.00 | 184% 16.34K to 46.34K | |
28-Nov-22 7:42 AM View: | Nrx Pharmaceuticals, Inc. (NRXP) | 25-Nov-22 | Private Purchase | 16,337 | $1.11 | $18,215.20 | 40842% 40 to 16.38K | |
17-Jun-21 6:52 PM View: | Pds Biotechnology Corp (PDSB) | 15-Jun-21 | Private Purchase | 17,647 | $8.50 | $150,000.00 | 100% 0 to 17.65K | |
24-Feb-20 4:30 PM View: | Research Frontiers Inc. (REFR) | 21-Feb-20 | Payment of Exercise | 91,554 | $1.36 | $124,963.00 | 66% 138.9K to 230.45K | |
13-Sep-17 8:30 AM View: | Research Frontiers Inc. (REFR) | 12-Sep-17 | Market Purchase | 4,000 | $1.15 | $4,600.00 | 3% 134.9K to 138.9K | 144% |
19-Jun-14 5:25 PM View: | Research Frontiers Inc. (REFR) | 19-Jun-14 | Market Purchase | 2,000 | $5.45 | $10,900.00 | 1% 144.9K to 146.9K | (49%) |
03-Jan-13 7:59 PM View: | Research Frontiers Inc. (REFR) | 01-Jan-13 | Grant | 56,200 | -- | -- | 63% 88.7K to 144.9K | |
04-Jan-12 5:27 PM View: | Research Frontiers Inc. (REFR) | 01-Jan-12 | Grant | 40,700 | -- | -- | 85% 48.0K to 88.7K | |
14-Feb-11 7:24 PM View: | Research Frontiers Inc. (REFR) | 10-Feb-11 | Market Purchase | 12,000 | $8.65 | $103,800.00 | 50% 24.0K to 36.0K | (68%) |
14-Feb-11 7:24 PM View: | Research Frontiers Inc. (REFR) | 10-Feb-11 | Market Purchase | 12,000 | $8.65 | $103,800.00 | 33% 36.0K to 48.0K | (68%) |
03-Mar-06 12:37 PM View: | American Pacific Corp. (APFC) | 01-Mar-06 | Market Purchase | 5,893 | $5.71 | $33,649.00 | 39% 15.0K to 20.89K | 752% |
21-Feb-06 7:23 PM View: | American Pacific Corp. (APFC) | 17-Feb-06 | Market Purchase | 15,000 | $5.58 | $83,627.90 | 100% 0 to 15.0K | 773% |